SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Smedh Kennet)
 

Search: WFRF:(Smedh Kennet) > (2010-2014) > Patients with recta...

  • Tiselius, CatarinaUppsala universitet,Centrum för klinisk forskning, Västerås (author)

Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival : a population-based longitudinal study

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • Oxford University Press,2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-83429
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-83429URI
  • https://doi.org/10.1093/annonc/mds278DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-181710URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:125865214URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND: The aim of this study was to investigate whether or not the use of adjuvant chemotherapy in stage III rectal cancer varies between regions and over time, and if this has had an effect on survival rates.PATIENTS AND METHODS: Patients from the Uppsala/Örebro region below 75 years-of-age, operated 1995-2002 and registered in the Swedish Rectal Cancer Register, were monitored between 1995 and September 2008. A multivariate Cox proportional hazard regression model was used for analysis. Overall survival was described using the Kaplan-Meier method.RESULTS: Four hundred and thirty-six patients with stage III rectal cancer were included. Adjuvant chemotherapy was given to 42% of the patients (proportions varying from 13% to 77% among counties), and there were substantial increases over time. The 5-year overall survival was 65.8% [95% confidence interval (CI) 50-84] for patients having adjuvant chemotherapy compared with 45.6% (95% CI 39-52) for patients not treated with chemotherapy. The multivariate hazard ratio for death was 0.65 (95% CI 0.5-0.8) for patients treated with adjuvant chemotherapy.CONCLUSIONS: The use of adjuvant chemotherapy for rectal cancer has increased, but varies considerably between hospitals/counties. In this cohort, those having adjuvant chemotherapy had a longer overall survival.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Gunnarsson, Ulf,1967-Karolinska Institutet(Swepub:umu)ulgu0014 (author)
  • Smedh, KennetUppsala universitet,Centrum för klinisk forskning, Västerås(Swepub:uu)kensm722 (author)
  • Glimelius, BengtUppsala universitet,Enheten för onkologi(Swepub:uu)bengglim (author)
  • Påhlman, LarsUppsala universitet,Kolorektalkirurgi(Swepub:uu)larspahl (author)
  • Uppsala universitetCentrum för klinisk forskning, Västerås (creator_code:org_t)

Related titles

  • In:Annals of Oncology: Oxford University Press24:1, s. 160-1650923-75341569-8041

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view